The money issue is a problem, whether or not investors want to admit it. Testing, even if the company is paid for it, isn't going to meet the cash burn. At some point, issuing more shares won't be viable. Maybe not now, but soon. Even if it funds the company, the dilution continues to reduce the per share value. But I guess that isn't a big deal...